Home
About
Overview
Sharing Data
ORCID
Help
History (42)
Evaluating Students' Use of Therapeutic Communication in Entry-Level Education: The Observer Version of the Clinical Assessment of Modes (CAM-Observer).
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.
The approach to the Jehovah's Witness patient.
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.
Long-term outcomes after treatment with interferon and ribavirin in HCV patients.
See All 42 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term outcomes after treatment with interferon and ribavirin in HCV patients.
Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol. 2009 Aug; 43(7):661-71.
View in:
PubMed
subject areas
Antiviral Agents
Clinical Trials as Topic
Drug Therapy, Combination
Hepatitis C, Chronic
Humans
Interferon-alpha
Polyethylene Glycols
Recombinant Proteins
Ribavirin
Treatment Outcome
authors with profiles
Nancy Reau